Brian Bor-Jen Liau

Title: Innovations and Contributions of Brian Bor-Jen Liau

Introduction

Brian Bor-Jen Liau is an accomplished inventor based in Belmont, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic compounds. With a total of 3 patents to his name, Liau's work focuses on innovative solutions for various medical conditions.

Latest Patents

Liau's latest patents include "Cortistatin analogues and syntheses and uses thereof." This patent provides compounds of Formula (A), (B), (C), (D), and (E), along with their pharmaceutically acceptable salts, quaternary amine salts, and N-oxides. These compounds are designed to be therapeutically useful for treating a wide range of conditions, particularly those associated with angiogenesis and CDK8 and/or CDK19 kinase activity. The patent also outlines methods for inhibiting CDK8 and/or CDK19 kinase activity, modulating the β-catenin pathway, and increasing BIM expression to induce apoptosis.

Career Highlights

Brian Bor-Jen Liau is affiliated with Harvard College, where he continues to advance his research and innovation in the pharmaceutical field. His work has garnered attention for its potential impact on therapeutic treatments.

Collaborations

Liau collaborates with notable colleagues, including Matthew D Shair and Juergen Ramharter, who contribute to his research endeavors and enhance the scope of his work.

Conclusion

Brian Bor-Jen Liau's innovative contributions to the field of pharmaceuticals demonstrate his commitment to advancing medical science. His patents and ongoing research hold promise for developing new therapeutic options for various health conditions.